144 related articles for article (PubMed ID: 35317546)
1. Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer.
Wang YF; Yin X; Fang TY; Wang YM; Zhang DX; Zhang Y; Wang XB; Wang H; Xue YW
World J Gastrointest Surg; 2022 Feb; 14(2):143-160. PubMed ID: 35317546
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study.
Terada M; Kinoshita T; Kaito A; Sugita S; Watanabe M; Hayashi R
Surg Today; 2018 Mar; 48(3):325-332. PubMed ID: 28993997
[TBL] [Abstract][Full Text] [Related]
3. Is surgery alone sufficient for treating T1 gastric cancer with extensive lymph node metastases?
Yura M; Yoshikawa T; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Gastric Cancer; 2020 Mar; 23(2):349-355. PubMed ID: 31512081
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer.
Wang YF; Yin X; Fang TY; Wang YM; Zhang L; Zhang XH; Zhang DX; Zhang Y; Wang XB; Wang H; Xue YW
World J Gastrointest Oncol; 2022 Apr; 14(4):897-919. PubMed ID: 35582101
[TBL] [Abstract][Full Text] [Related]
5. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy.
Wang N; Xi W; Lu S; Jiang J; Wang C; Zhu Z; Yan C; Liu J; Zhang J
Front Oncol; 2021; 11():650562. PubMed ID: 34195071
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer.
Yin X; Fang T; Wang Y; Wang Y; Zhang D; Li C; Xue Y
Cancer Med; 2021 Feb; 10(3):1103-1119. PubMed ID: 33410261
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
8. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
9. Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer.
Wang H; Yin X; Ma K; Wang Y; Fang T; Zhang Y; Xue Y
J Inflamm Res; 2023; 16():1059-1075. PubMed ID: 36936348
[TBL] [Abstract][Full Text] [Related]
10. Preoperative CA19-9 is a prognostic factor in pT3N0 gastric cancer patients undergoing curative resection.
Maruyama T; Akashi Y; Hakoda H; Sako A; Ueda K; Kato S; Azuma K; Kaneko Y; Ikeguchi A; Nagai S; Oda T
Langenbecks Arch Surg; 2022 Sep; 407(6):2273-2279. PubMed ID: 35551467
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of the preoperative New-Naples prognostic score for patients with gastric cancer.
Wang H; Fang T; Yin X; Lou S; Han B; Gao J; Wang Y; Wang X; Zhang D; Wang Y; Zhang Y; Xue Y
Cancer Med; 2023 Jan; 12(2):1358-1375. PubMed ID: 35833662
[TBL] [Abstract][Full Text] [Related]
12. Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy.
Mu GC; Huang Y; Liu ZM; Wu XH; Qin XG; Chen ZB
BMC Gastroenterol; 2019 Nov; 19(1):188. PubMed ID: 31729975
[TBL] [Abstract][Full Text] [Related]
13. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
14. Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy?
Chen QY; Zhong Q; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Zheng CH; Huang CM
Ann Surg Oncol; 2019 Jun; 26(6):1759-1771. PubMed ID: 30756329
[TBL] [Abstract][Full Text] [Related]
15. A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer Patients.
Wang X; Mao M; Zhu S; Xing S; Song Y; Zhang L; Chi P
Adv Ther; 2020 Jun; 37(6):2902-2915. PubMed ID: 32363466
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Postoperative FOLFOX
Yin X; Fang T; Wang Y; Li C; Wang Y; Zhang D; Xue Y
Front Oncol; 2020; 10():584772. PubMed ID: 33425738
[TBL] [Abstract][Full Text] [Related]
17. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
18. Exploratory Analysis to Find Unfavorable Subset of Stage II Gastric Cancer for Which Surgery Alone Is the Standard Treatment; Another Target for Adjuvant Chemotherapy.
Aoyama T; Yoshikawa T; Fujikawa H; Hayashi T; Ogata T; Cho H; Yamada T; Hasegawa S; Tsuchida K; Yukawa N; Oshima T; Rino Y; Masuda M
Int Surg; 2014; 99(6):835-41. PubMed ID: 25437596
[TBL] [Abstract][Full Text] [Related]
19. [A nomogram for predicting lymph node metastasis in early gastric cancer].
Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
[No Abstract] [Full Text] [Related]
20. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
